RE
MDCO

RBC Europe’s Medicines Co MDCO Stock Holding History

RBC Europe’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,000
Closed -$50K – 1072
2019
Q3 		$50K Hold
1,000
– – ﹤0.01% 438
2019
Q2 		$36.5K Hold
1,000
– – ﹤0.01% 530
2019
Q1 		$27.9K Hold
1,000
– – ﹤0.01% 586
2018
Q4 		$19.1K Hold
1,000
– – ﹤0.01% 639
2018
Q3 		$29.9K Hold
1,000
– – ﹤0.01% 592
2018
Q2 		$36.7K Hold
1,000
– – ﹤0.01% 533
2018
Q1 		$32.9K Hold
1,000
– – ﹤0.01% 563
2017
Q4 		$27.3K Buy
+1,000
New +$30.8K ﹤0.01% 615

Other funds holding MDCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

RBC Europe's MDCO Position: Q4 2019 in Review

RBC Europe sold out of Medicines Co (MDCO) in Q4 2019, closing a stake of 1,000 shares — an estimated $50K sold.

RBC Europe first reported a position in MDCO in Q4 2017 and held it in 8 quarters. The position peaked at $50K in Q3 2019. 284 funds tracked by Wall St. Rank hold MDCO as of Q4 2019.

  • RBC Europe reported no remaining Medicines Co position as of Q4 2019 after selling out during the quarter.
  • RBC Europe sold 1,000 Medicines Co shares in Q4 2019, an estimated $50K.
  • RBC Europe first reported a position in Medicines Co in Q4 2017 and held it in 8 quarters.
  • RBC Europe's Medicines Co position peaked at $50K in Q3 2019.
  • 284 funds tracked by Wall St. Rank held Medicines Co as of Q4 2019.

Based on RBC Europe's 13F filing for Q4 2019, filed 9 Nov 2023.